PTPCGrimAge3Biomarker1 paperHuman trial1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01Journal of the American Academy of DermatologyHuman trial·19 AugThe effects of tildrakizumab in the epigenetic aging deviation of psoriasis: A 52-week open-label studyPsoriasis
Journal of the American Academy of DermatologyHuman trial·19 AugThe effects of tildrakizumab in the epigenetic aging deviation of psoriasis: A 52-week open-label studyPsoriasis